甲基普雷迪尼索隆在重症COVID-19患者中的作用:一个元分析
Wanru Xu1, Yujun Zeng1, Hedong Han2
1Department of Respiratory and Critical Care Medicine, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Nanjing Medical University, Suzhou, China.
Frontiers in medicine
|August 26, 2024
概括
甲基普雷尼索隆在严重的COVID-19患者中显著降低死亡率,而不会增加不良事件. 还观察到高剂量,短期治疗以及对年轻患者的益处,这表明其在治疗严重疾病方面的有效性.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 严重的COVID-19是一个重大的全球健康挑战.
- 皮质类固醇,包括甲基prednisolone,正在研究它们在严重感染中的抗炎作用.
- 了解甲基普雷迪尼索隆对COVID-19死亡率和安全性的特定影响至关重要.
研究的目的:
- 评估甲基普雷迪尼索隆在降低严重COVID-19患者死亡率方面的疗效.
- 评估甲基普雷迪尼索隆的安全性,特别是关于不良事件的安全性.
- 探索基于剂量,持续时间和患者年龄的差异性影响.
主要方法:
- 在PubMed,Cochrane图书馆和科学网上进行了系统的文献搜索.
- 对13项涉及3138名严重COVID-19患者的研究进行了元分析 (1,634名甲基prednisolone,1,504名对照).
- 风险比率 (RR) 与95%信心区间 (CI) 为死亡率和不良事件计算.
主要成果:
- 甲基普雷迪尼索隆的使用与死亡率显著降低有关 (RR 0.62;95% CI 0.46-0.85;p=0.003).
- 没有观察到增加不良事件的风险 (RR 1.20;95% CI 0.92-1.56;p=0.17).
- 高剂量 (RR 0.57) 和短期 (RR 0.54) 治疗显示出显著的死亡率降低;年轻患者受益更多 (RR 0.40).
结论:
- 甲基普雷迪尼索隆有效降低严重的COVID-19患者的死亡率.
- 治疗不会增加严重不良反应的风险.
- 建议使用高剂量,短期治疗方案获得最佳结果,特别是在年轻患者中.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
190
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
190
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
98
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
230
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
230
01:24Antiasthma Drugs: Methylxanthines
211
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
211
01:28Pneumonia IV: Management
312
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
312
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145